Nachrichten zur Pfizer Inc. Aktie

The State of Weight Loss Drugs

In this podcast, Motley Fool analyst Karl Thiel joins host Ricky Mulvey to check in on the GLP-1 landscape. They…

Pfizer Stock Up Almost 6% in 3 Months: Time to Buy, Sell or Hold?

Investors may stay invested in PFE stock to see how its new growth drivers perform.…

3 ETFs to Buy Now for Passive Dividend Income

With volatility spiking and stock market indexes like the S&P 500 (SNPINDEX: ^GSPC) and Nasdaq Composite (NASDAQINDEX: ^IXIC) down on…

Is Pfizer Inc. (PFE) The Best Cheap Dividend Stock To Buy Right Now?

We recently published a list of 13 Best Cheap Dividend Stocks To Buy Right Now. In this article, we are…

3 Top Dividend Stocks to Buy in March

Investing in dividend stocks can be a great strategy, especially if you pick solid companies that pay reliable and high-yield…

Pfizer Aktie: Satte Ausschüttungen für Anleger

Kulmbach (www.aktiencheck.de) - Pfizer-Aktienanalyse von "Der Aktionär": Michel Doepke vom Anlegermagazin "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die Aktie von…

Pfizer Vs. Johnson & Johnson: Whos The Better Bargain For Investors

…

President Trumps Trade War Is On. Here are 3 Things Every Investor Should Do.

After two years of double-digit gains, the S&P 500 (SNPINDEX: ^GSPC) lost its momentum -- at least temporarily -- in…

Berenberg senkt Ziel für Pfizer auf 28 Dollar - Hold

HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat das Kursziel für Pfizer von 29 auf 28 US-Dollar gesenkt und die…

Pfizer (PFE) Down 1.9% Since Last Earnings Report: Can It Rebound?

Pfizer (PFE) reported earnings 30 days ago. Whats next for the stock? We take a look at earnings estimates for…

Why Moderna Stock Zoomed Nearly 16% Higher on Wednesday

A big legal victory across the Atlantic Ocean was the news propelling Moderna (NASDAQ: MRNA) stock to a significant price…

Urteil in erster Instanz: Moderna gewinnt Patentstreit gegen Biontech und Pfizer

Für seinen Corona-Impfstoff benutzt Biontech/Pfizer auch Patente von Moderna - und zahlt dafür kein Geld. Den Streit zwischen den beiden…

Biontech und Pfizer: Niederlage im Patentstreit mit Moderna

Moderna hat eine Klage gegen Pfizer und Biontech gewonnen. Das Unternehmen hatte den Konkurrenten vorgeworfen, Technologien kopiert zu haben. Die…

Moderna gewinnt mit Patentklage gegen Biontech

DÜSSELDORF (dpa-AFX) - Der Impfstoffhersteller Moderna hat mit einer Patentklage gegen die Unternehmen Biontech und Pfizer in…

Moderna: Schlappe in Patentstreit vor Gericht für Biontech und Pfizer

Moderna hatte gegen Pfizer und Biontech wegen einer Verletzung von Patentrechten geklagt. Die Unternehmen gaben zu, das Patent genutzt zu…

German court rules Pfizer, BioNTech infringed Moderna’s COVID-19 vaccine patent By Investing.com

German court rules Pfizer, BioNTech infringed Moderna’s COVID-19 vaccine patent…

German court rules Pfizer, BioNTech violated Moderna’s COVID-19 vaccine patent By Reuters

German court rules Pfizer, BioNTech violated Moderna’s COVID-19 vaccine patent…

German court rules Pfizer, BioNTech violated Modernas COVID-19 vaccine patent

A German court in Duesseldorf on Wednesday ruled that Pfizer and its partner BioNTech violated a COVID-19 vaccine patent held…

1 Stock Down 43% That Looks Too Cheap to Ignore

Shrewd investors know that bear markets open up great opportunities to pick up shares of excellent companies from the discount…

"Haben hier alle Möglichkeiten": Pfizer denkt wegen US-Zöllen an Produktionsverlagerung

Bald könnte eine Entscheidung von US-Präsident Donald Trump zu Strafzöllen gegen die EU führen. Der Pharmakonzern Pfizer überlegt deswegen, die…

Pfizer could use existing US manufacturing to counter potential tariff hit By Reuters

Pfizer could use existing US manufacturing to counter potential tariff hit…

Pfizer could move outside manufacturing to the US, says CEO

Pfizer CEO Albert Bourla said on Monday the drugmaker might move overseas manufacturing to the U.S., if required, as President…

Pfizer considers moving overseas production to U.S. amid tariff threats By Investing.com

Pfizer considers moving overseas production to U.S. amid tariff threats…

2 Top Stocks Beaten Down Near 52-Week Lows That Look Like Bargains Now

Buying low to sell later when the stocks price is high is a time-honored investing strategy. With the benchmark S&P…

The top 100 biotech investors; FDA vaccine meeting canceled; Can Bill Anderson save Bayer?; and more

Biotech investing saw growth in 2024, with RA Capital leading VCs. FDA cancels flu vaccine meeting, Pfizer hires ex-FDA official…

3 Dividend Stocks That Are No-Brainer Buys Right Now

It can be difficult to decide which dividend stocks to buy. After all, more than 5,700 of them trade on…

Activist Starboard Trailed Peers With Less Than 5% Returns

Starboard Value LP underperformed peers in 2024, a year in which Jeff Smith’s activist firm was frustrated with large campaigns…

The Zacks Analyst Blog Highlights Alibaba, Pfizer, MercadoLibre and SIFCO

Alibaba, Pfizer, MercadoLibre and SIFCO are included in this Analyst Blog.…

Top Research Reports for Alibaba, Pfizer & MercadoLibre

Todays Research Daily features new research reports on 16 major stocks, including Alibaba Group Holding Limited (BABA), Pfizer Inc. (PFE)…

Pfizer: What The Summit Therapeutics Deal Brings

…

Pfizer: No More Growth - Still A Worthy Dividend Buy

…

3 Magnificent Dividend Growth Stocks With Yields Above 5% to Buy Now and Hold at Least a Decade

There are many ways to make money on Wall Street, but some methods are a lot more reliable than others.…

2 No-Brainer Healthcare Stocks to Buy With $500 Right Now

Looking for a good area in which to invest? Consider the healthcare sector. People must have healthcare. And with aging…

Pfizer: Pharma-Riese zieht die Reißleine

Keine guten Nachrichten vom US-amerikanischen Pharma-Giganten. Pfizer nimmt seine Gentherapie zur Behandlung der Hämophilie (Bluterkrankheit) vom Markt. Ein weiterer Rückschlag…

Pfizer ends global development of Beqvez gene therapy By Investing.com

Pfizer ends global development of Beqvez gene therapy…

The Smartest Dividend Stocks to Buy With $1,000 Right Now

You have $1,000 (or $200 or $50,000) burning a hole in your pocket and youre itching to invest in some…

Why Pfizers Stock Price Isnt Reflecting Its True Value

…

10 Key Sustainable-Investing Themes and Companies

The charms of IBM, EDP Renovaveis, Pfizer, Baker Hughes, Barclays, and others.…

Love, Money, and Stocks

In this podcast, Motley Fool host Dylan Lewis and analysts Jason Moser and Emily Flippen break down: The Trade Desks 30%…

This Company Just Initiated a Quarterly Dividend: Time to Buy?

Biotech giant Renegeron Pharmaceuticals (NASDAQ: REGN) reported its fourth-quarter and full-year 2024 earnings on Feb. 4. The companys results were…

Want Decades of Passive Income? Buy This ETF and Hold It Forever.

Who doesnt want passive income? Even Warren Buffett has extolled it, reportedly saying, "If you dont find a way to…

3 Things You Need to Know If You Buy Pfizer Today

Pfizer (NYSE: PFE) has been around for 175 years, but the companys revenue soared to its highest ever only in…

3 Magnificent Stocks to Buy That Are Near 52-Week Lows

Buy low, sell high. That has been a good strategy for investors for a long time. However, finding great stocks…

GSK meningitis jab gets green light from US FDA

GSK PLC has bagged approval for its five-in-one meningitis vaccine from the US Food and Drug Administration, meaning it will…

Pfizer: Danuglipron Could Tip The Scale In A Few Years, But For Now, Sell

…

Commerzbank, Rheinmetall, RWE, Pfizer, AMD, Adobe, UnitedHealth: Die Insider sind am Kaufen

Ziemlich aktiv sind die Insider bei Rheinmetall, Commerzbank, Adobe, Pfizer, AMD, UnitedHealth und RWE. Deren Vorstände kauften überwiegend… Der Beitrag Commerzbank,…

Pfizer wins 2025 Super Bowl with ads likeability, while Hims & Hers spot takes engagement crown: analysts

Hims & Hers’ 2025 Super Bowl commercial generated plenty of c | Hims & Hers “Sick of the System” spot…

Better High-Yield Dividend Stock: Pfizer vs. Merck

Investors looking for ways to pump up their passive income streams might want to turn their heads toward the pharmaceutical…

3 No-Brainer Healthcare Stocks to Buy With $200 Right Now

Healthcare stocks have something to offer every investor. If youre looking for high growth, you can try an innovative biotech…

Deutsche Bank Research belässt GSK auf Hold - Ziel 1450 Pence

FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für GSK nach Zahlen und einem Treffen mit dem Management…